The Valley Desk

NCT04452214 · Interventional trial

A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors

Overall registry status Completed

Phase 1

Conditions Carcinoma, Non-Small-Cell Lung, Head and Neck Squamous Cell Carcinoma, Malignant Melanoma, Urothelial Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov